HK Stock MarketDetailed Quotes

CMOC (03993)

Watchlist
  • 18.800
  • +2.040+12.17%
15min DelayNot Open Jun 12 16:07 CST
402.21BMarket Cap14.70P/E (TTM)

CMOC (03993) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Turnover
44.34%66.4B
-2.98%206.68B
-5.99%145.49B
-7.83%94.77B
-0.25%46.01B
14.37%213.03B
17.52%154.75B
18.56%102.82B
4.15%46.12B
7.68%186.27B
Operating income
44.34%66.4B
-2.98%206.68B
-5.99%145.49B
-7.83%94.77B
-0.25%46.01B
14.37%213.03B
17.52%154.75B
18.56%102.82B
4.15%46.12B
7.68%186.27B
Operating expenses
-43.31%-51.21B
11.56%-157.23B
10.94%-113.53B
10.96%-74.73B
11.17%-35.73B
-5.72%-177.77B
-4.12%-127.48B
-1.11%-83.92B
5.34%-40.22B
-7.16%-168.16B
Gross profit
47.89%15.2B
40.28%49.45B
17.14%31.95B
6.09%20.05B
74.17%10.28B
94.66%35.25B
194.94%27.28B
407.61%18.89B
229.29%5.9B
12.74%18.11B
Selling expenses
23.35%-20.72M
-12.94%-104.85M
-11.76%-80.88M
-3.63%-56.53M
-33.12%-27.04M
40.27%-92.83M
41.98%-72.36M
5.96%-54.55M
-8.51%-20.31M
-59.94%-155.42M
Administrative expenses
-47.50%-755.01M
-31.91%-2.81B
-4.90%-1.83B
3.02%-1.13B
31.61%-511.89M
10.85%-2.13B
5.14%-1.74B
3.69%-1.17B
-45.84%-748.52M
-33.27%-2.39B
Research and development expenses
-14.26%-118.78M
-21.95%-431.68M
-47.65%-331.62M
-59.78%-219.23M
-100.70%-103.95M
-8.22%-353.97M
-2.01%-224.61M
-27.41%-137.21M
-43.34%-51.8M
15.83%-327.09M
Profit from asset sales
99.12%-86.31K
-127.70%-18.42M
-298.74%-34.84M
-164.78%-9.61M
-338.02%-9.76M
2,245.13%66.48M
88.34%17.53M
82.16%14.84M
-87.35%4.1M
-90.27%2.83M
Revaluation surplus
75.28%-481.4M
-458.89%-7.69B
33.43%-2.39B
62.17%-1.15B
-5,308.53%-1.95B
-181.86%-1.38B
-300.47%-3.59B
-341.06%-3.05B
121.96%37.39M
204.33%1.68B
-Changes in the fair value of other assets
75.28%-481.4M
-458.89%-7.69B
33.43%-2.39B
62.17%-1.15B
-5,308.53%-1.95B
-181.86%-1.38B
-300.47%-3.59B
-341.06%-3.05B
121.96%37.39M
204.33%1.68B
Impairment and provision
-48.62%5.71M
79.76%-40.68M
8,698.01%9.09M
-21.71%6.27M
330.56%11.11M
-39.21%-200.92M
100.17%103.35K
126.87%8.01M
10.47%-4.82M
-69.90%-144.33M
-Other impairment is provision
-48.62%5.71M
79.76%-40.68M
8,698.01%9.09M
-21.71%6.27M
330.56%11.11M
-39.21%-200.92M
100.17%103.35K
126.87%8.01M
10.47%-4.82M
-69.90%-144.33M
Special items of operating profit
224.88%497.78M
-24.11%842.27M
-32.47%500.4M
-17.12%307.23M
113.65%153.22M
-57.24%1.11B
140.38%741.01M
27.72%370.67M
-66.12%71.72M
219.92%2.6B
Operating profit
90.69%13.05B
27.34%35.84B
30.35%25.19B
23.61%15.94B
60.76%6.84B
72.75%28.14B
170.71%19.33B
327.05%12.89B
294.42%4.26B
39.28%16.29B
Financing income
11.86%443.65M
-0.31%1.64B
-0.48%1.19B
8.56%798.76M
20.22%396.62M
0.39%1.65B
0.25%1.2B
-6.66%735.75M
-13.94%329.92M
38.20%1.64B
Financing cost
-13.41%-784.68M
34.94%-2.63B
36.89%-1.97B
34.34%-1.37B
27.52%-691.88M
2.29%-4.04B
0.24%-3.11B
0.04%-2.09B
7.98%-954.63M
-48.05%-4.14B
Special items of earning before tax
-17.65%-33.49M
-17.11%-166.3M
-187.98%-93.18M
-946.13%-56.93M
-293.99%-28.46M
-77.46%-142M
48.91%-32.36M
130.00%6.73M
377.64%14.67M
5.41%-80.01M
Earning before tax
93.72%12.17B
39.95%35.16B
43.87%24.07B
33.62%14.9B
77.39%6.28B
90.22%25.12B
232.16%16.73B
585.59%11.15B
721.22%3.54B
34.71%13.21B
After-tax profit from continuing operations
100.06%8.82B
54.17%23.75B
73.16%16.49B
55.49%9.84B
89.12%4.41B
128.04%15.41B
339.11%9.52B
1,123.71%6.33B
754.32%2.33B
-4.63%6.76B
After-tax profit from non-continuing business
----
425.87%273.05M
----
----
----
-97.07%51.92M
----
----
----
1,557.01%1.77B
Earning after tax
100.06%8.82B
55.42%24.03B
73.16%16.49B
55.49%9.84B
89.12%4.41B
81.22%15.46B
318.75%9.52B
929.00%6.33B
754.32%2.33B
18.62%8.53B
Minority profit
129.00%1.06B
91.38%3.69B
76.83%2.21B
28.32%1.17B
78.37%464.43M
586.13%1.93B
838.21%1.25B
1,138.27%913.13M
689.81%260.38M
-75.02%280.91M
Profit attributable to shareholders
96.65%7.76B
50.30%20.34B
72.61%14.28B
60.07%8.67B
90.47%3.95B
64.03%13.53B
238.62%8.27B
670.43%5.42B
553.28%2.07B
35.98%8.25B
Basic earnings per share
100.00%0.36
50.79%0.95
71.79%0.67
64.00%0.41
80.00%0.18
65.79%0.63
254.55%0.39
733.33%0.25
566.67%0.1
35.71%0.38
Diluted earnings per share
100.00%0.36
50.79%0.95
71.79%0.67
64.00%0.41
80.00%0.18
65.79%0.63
254.55%0.39
733.33%0.25
566.67%0.1
35.71%0.38
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)
--
--
--
Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)
--
--
--
Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Turnover 44.34%66.4B-2.98%206.68B-5.99%145.49B-7.83%94.77B-0.25%46.01B14.37%213.03B17.52%154.75B18.56%102.82B4.15%46.12B7.68%186.27B
Operating income 44.34%66.4B-2.98%206.68B-5.99%145.49B-7.83%94.77B-0.25%46.01B14.37%213.03B17.52%154.75B18.56%102.82B4.15%46.12B7.68%186.27B
Operating expenses -43.31%-51.21B11.56%-157.23B10.94%-113.53B10.96%-74.73B11.17%-35.73B-5.72%-177.77B-4.12%-127.48B-1.11%-83.92B5.34%-40.22B-7.16%-168.16B
Gross profit 47.89%15.2B40.28%49.45B17.14%31.95B6.09%20.05B74.17%10.28B94.66%35.25B194.94%27.28B407.61%18.89B229.29%5.9B12.74%18.11B
Selling expenses 23.35%-20.72M-12.94%-104.85M-11.76%-80.88M-3.63%-56.53M-33.12%-27.04M40.27%-92.83M41.98%-72.36M5.96%-54.55M-8.51%-20.31M-59.94%-155.42M
Administrative expenses -47.50%-755.01M-31.91%-2.81B-4.90%-1.83B3.02%-1.13B31.61%-511.89M10.85%-2.13B5.14%-1.74B3.69%-1.17B-45.84%-748.52M-33.27%-2.39B
Research and development expenses -14.26%-118.78M-21.95%-431.68M-47.65%-331.62M-59.78%-219.23M-100.70%-103.95M-8.22%-353.97M-2.01%-224.61M-27.41%-137.21M-43.34%-51.8M15.83%-327.09M
Profit from asset sales 99.12%-86.31K-127.70%-18.42M-298.74%-34.84M-164.78%-9.61M-338.02%-9.76M2,245.13%66.48M88.34%17.53M82.16%14.84M-87.35%4.1M-90.27%2.83M
Revaluation surplus 75.28%-481.4M-458.89%-7.69B33.43%-2.39B62.17%-1.15B-5,308.53%-1.95B-181.86%-1.38B-300.47%-3.59B-341.06%-3.05B121.96%37.39M204.33%1.68B
-Changes in the fair value of other assets 75.28%-481.4M-458.89%-7.69B33.43%-2.39B62.17%-1.15B-5,308.53%-1.95B-181.86%-1.38B-300.47%-3.59B-341.06%-3.05B121.96%37.39M204.33%1.68B
Impairment and provision -48.62%5.71M79.76%-40.68M8,698.01%9.09M-21.71%6.27M330.56%11.11M-39.21%-200.92M100.17%103.35K126.87%8.01M10.47%-4.82M-69.90%-144.33M
-Other impairment is provision -48.62%5.71M79.76%-40.68M8,698.01%9.09M-21.71%6.27M330.56%11.11M-39.21%-200.92M100.17%103.35K126.87%8.01M10.47%-4.82M-69.90%-144.33M
Special items of operating profit 224.88%497.78M-24.11%842.27M-32.47%500.4M-17.12%307.23M113.65%153.22M-57.24%1.11B140.38%741.01M27.72%370.67M-66.12%71.72M219.92%2.6B
Operating profit 90.69%13.05B27.34%35.84B30.35%25.19B23.61%15.94B60.76%6.84B72.75%28.14B170.71%19.33B327.05%12.89B294.42%4.26B39.28%16.29B
Financing income 11.86%443.65M-0.31%1.64B-0.48%1.19B8.56%798.76M20.22%396.62M0.39%1.65B0.25%1.2B-6.66%735.75M-13.94%329.92M38.20%1.64B
Financing cost -13.41%-784.68M34.94%-2.63B36.89%-1.97B34.34%-1.37B27.52%-691.88M2.29%-4.04B0.24%-3.11B0.04%-2.09B7.98%-954.63M-48.05%-4.14B
Special items of earning before tax -17.65%-33.49M-17.11%-166.3M-187.98%-93.18M-946.13%-56.93M-293.99%-28.46M-77.46%-142M48.91%-32.36M130.00%6.73M377.64%14.67M5.41%-80.01M
Earning before tax 93.72%12.17B39.95%35.16B43.87%24.07B33.62%14.9B77.39%6.28B90.22%25.12B232.16%16.73B585.59%11.15B721.22%3.54B34.71%13.21B
After-tax profit from continuing operations 100.06%8.82B54.17%23.75B73.16%16.49B55.49%9.84B89.12%4.41B128.04%15.41B339.11%9.52B1,123.71%6.33B754.32%2.33B-4.63%6.76B
After-tax profit from non-continuing business ----425.87%273.05M-------------97.07%51.92M------------1,557.01%1.77B
Earning after tax 100.06%8.82B55.42%24.03B73.16%16.49B55.49%9.84B89.12%4.41B81.22%15.46B318.75%9.52B929.00%6.33B754.32%2.33B18.62%8.53B
Minority profit 129.00%1.06B91.38%3.69B76.83%2.21B28.32%1.17B78.37%464.43M586.13%1.93B838.21%1.25B1,138.27%913.13M689.81%260.38M-75.02%280.91M
Profit attributable to shareholders 96.65%7.76B50.30%20.34B72.61%14.28B60.07%8.67B90.47%3.95B64.03%13.53B238.62%8.27B670.43%5.42B553.28%2.07B35.98%8.25B
Basic earnings per share 100.00%0.3650.79%0.9571.79%0.6764.00%0.4180.00%0.1865.79%0.63254.55%0.39733.33%0.25566.67%0.135.71%0.38
Diluted earnings per share 100.00%0.3650.79%0.9571.79%0.6764.00%0.4180.00%0.1865.79%0.63254.55%0.39733.33%0.25566.67%0.135.71%0.38
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)------Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)------Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More